NIVF
Price
$0.29Alerts
Change
+$0.01 (+3.57%)
Updated
Nov 11 closing price
Capitalization
1.1M
Intraday BUY SELL Signals
PIII
Price
$2.61Alerts
Change
-$0.77 (-22.78%)
Updated
Nov 11 closing price
Capitalization
15.65M
140 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NIVF vs PIII

NIVF vs PIII Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NIVF vs. PIII commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NIVF is a Buy and PIII is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NIVF with price predictions
Nov 11, 2026

NIVF in +13.24% Uptrend, rising for three consecutive days on October 19, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NIVF advanced for three days, in 67 of 80 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NIVF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for NIVF entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.041) is normal, around the industry mean (204.532). P/E Ratio (0.000) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.005) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. NIVF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NIVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for PIII with price predictions
Nov 11, 2026

PIII in +11.26% Uptrend, growing for three consecutive days on November 09, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PIII advanced for three days, in 197 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for PIII's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Moving Average Convergence Divergence (MACD) for PIII just turned positive on October 22, 2026. Looking at past instances where PIII's MACD turned positive, the stock continued to rise in 29 of 35 cases over the following month. The odds of a continued upward trend are 83%.

PIII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PIII as a result. In 79 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The 50-day moving average for PIII moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PIII declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PIII entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.170) is normal, around the industry mean (204.532). P/E Ratio (-0.121) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. PIII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PIII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
NIVFPIII
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
84%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (NIVF: $0.28 vs. PIII: $3.38)
Brand notoriety: NIVF and PIII are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: NIVF: 31% vs. PIII: 1436%
Market capitalization -- NIVF: $1.1M vs. PIII: $15.65M
NIVF [@Hospital/Nursing Management] is valued at $1.1M. PIII’s [@Hospital/Nursing Management] market capitalization is $15.65M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NIVF’s FA Score shows that 1 FA rating(s) are green while PIII’s FA Score has 2 green FA rating(s).

  • NIVF’s FA Score: 1 green, 4 red.
  • PIII’s FA Score: 2 green, 3 red.
According to our system of comparison, PIII is a better buy in the long-term than NIVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NIVF’s TA Score shows that 2 TA indicator(s) are bullish while PIII’s TA Score has 4 bullish TA indicator(s).

  • NIVF’s TA Score: 2 bullish, 2 bearish.
  • PIII’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NIVF and PIII are a good buy in the short-term.

Price Growth

NIVF (@Hospital/Nursing Management) experienced а -66.71% price change this week, while PIII (@Hospital/Nursing Management) price change was -11.98% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -5.65%. For the same industry, the average monthly price growth was +0.49%, and the average quarterly price growth was +11.07%.

Reported Earning Dates

PIII is expected to report earnings on Apr 01, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-5.65% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

NIVF and

Correlation & Price change

A.I.dvisor tells us that NIVF and BMGL have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NIVF and BMGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NIVF
1D Price
Change %
NIVF100%
+3.18%
BMGL - NIVF
8%
Poorly correlated
-64.56%
UHS - NIVF
7%
Poorly correlated
+0.70%
ASTH - NIVF
7%
Poorly correlated
+2.36%
PIII - NIVF
6%
Poorly correlated
-22.78%
DVA - NIVF
4%
Poorly correlated
+2.35%
More

PIII and

Correlation & Price change

A.I.dvisor tells us that PIII and ADUS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PIII and ADUS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PIII
1D Price
Change %
PIII100%
-22.78%
ADUS - PIII
24%
Poorly correlated
-0.63%
SGRY - PIII
23%
Poorly correlated
-0.26%
ENSG - PIII
21%
Poorly correlated
+0.59%
OPCH - PIII
21%
Poorly correlated
+0.16%
HCSG - PIII
21%
Poorly correlated
-0.36%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNSS1.450.04
+2.84%
Genasys
IDT83.05-0.17
-0.20%
IDT Corp
BAH86.89-0.53
-0.61%
Booz Allen Hamilton Holding Corp
CHCT15.01-0.26
-1.70%
Community Healthcare Trust
CDT0.51-0.05
-9.14%
Cdt Equity Inc